Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Dig Dis Sci. 2015 Jul 5;60(11):3491–3494. doi: 10.1007/s10620-015-3771-0

Table 1.

Plasma Sildenafil and N-Desmethyl Sildenafil Concentrations in Two Subjects with CTP Class C Cirrhosis and Renal Dysfunction

Subject 1 Time after Sildenafil
Injection (minutes)
Sildenafil
Concentration
(ng/mL)
N-desmethyl Sildenafil
Concentration
(ng/mL)
Mean
Arterial
Pressure
(mmHg)*
Heart
Rate*
1 Predose BLQ BLQ 87 50
1 16 35.0 1.21 75 53
1 30 25.7 BLQ 78 53
1 60 25.9 2.26 78 55
1 88 31.9 2.10 N/A N/A
1 120 21.6 2.49 75 51
1 178 23.5 2.64 79 50
1 242 26.7 2.19 78 50
1 360 5.01 2.00 83 53
1 480 3.87 1.53 83 54
Subject 2 Time after Sildenafil
Injection (minutes)
Sildenafil
Concentration
(ng/mL)
N-desmethyl Sildenafil
Concentration
(ng/mL)
Mean
Arterial
Pressure
(mmHg)*
Heart
Rate*
2 Predose BLQ BLQ 77 98
2 15 20.6 BLQ 69 98
2 30 16.0 BLQ 73 98
2 60 13.5 BLQ 75 98
2 90 12.0 BLQ N/A N/A
2 122 12.0 BLQ 81 90
2 180 10.2 1.06 80 97
2 240 9.79 BLQ 75 93
2 360 7.08 BLQ 72 92
2 480 8.02 BLQ 75 94

BLQ=Below llimit of quantitation

*

At few time points, MAP and heart rate were measured 1 or 2 minutes earlier or later than plasma sildenafil and N-desmethyl sildenafil concentrations.